A study to evaluate the factors which predicts the survival of lung cancer patients with their performance status.
Not Applicable
- Conditions
- Health Condition 1: null- Patients of Advanced Lung Cancer
- Registration Number
- CTRI/2014/11/005216
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
•Diagnosis: - Histopathological or cytological proven NSCLC.
•PS: - 3, 4
•Chemotherapy naive.
•Intent of therapy is palliative.
•Age > 18 years
Exclusion Criteria
No Exclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the factors affecting the outcome (Overall Survival) of all NSCLC patients with compromised PS (PS2) whether offered treatment or not. <br/ ><br>Timepoint: 6 months
- Secondary Outcome Measures
Name Time Method 1)Evaluate if active therapy improves the quality of life of patients with NSCLC with compromised PS <br/ ><br>2)Evaluate the toxicity of treatment administered to patients with NSCLC with compromised PS. <br/ ><br>Timepoint: 6 months